Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895069402> ?p ?o ?g. }
- W2895069402 endingPage "260" @default.
- W2895069402 startingPage "1" @default.
- W2895069402 abstract "Background Dynamic Spectral Imaging System (DySIS)map (DySIS Medical Ltd, Edinburgh, UK) and ZedScan (Zilico Limited, Manchester, UK) can be used adjunctively with conventional colposcopy, which may improve the detection of cervical intraepithelial neoplasia (CIN) and cancer. Objectives To systematically review the evidence on the diagnostic accuracy, clinical effectiveness and implementation of DySISmap and ZedScan as adjuncts to standard colposcopy, and to develop a cost-effectiveness model. Methods Four parallel systematic reviews were performed on diagnostic accuracy, clinical effectiveness issues, implementation and economic analyses. In January 2017 we searched databases (including MEDLINE and EMBASE) for studies in which DySISmap or ZedScan was used adjunctively with standard colposcopy to detect CIN or cancer in women referred to colposcopy. Risk of bias was assessed with the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 tool. Summary estimates of diagnostic accuracy were calculated using bivariate and other regression models when appropriate. Other outcomes were synthesised narratively. A patient-level state-transition model was developed to evaluate the cost-effectiveness of DySISmap and ZedScan under either human papillomavirus (HPV) triage or the HPV primary screening algorithm. The model included two types of clinics [‘see and treat’ and ‘watchful waiting’ (i.e. treat later after confirmatory biopsy)], as well as the reason for referral (low-grade or high-grade cytological smear). Sensitivity and scenario analyses were undertaken. Results Eleven studies were included in the diagnostic review (nine of DySISmap and two of ZedScan), three were included in the clinical effectiveness review (two of DySISmap and one of ZedScan) and five were included in the implementation review (four of DySISmap and one of ZedScan). Adjunctive DySISmap use was found to have a higher sensitivity for detecting CIN grade 2+ (CIN 2+) lesions [81.25%, 95% confidence interval (CI) 72.2% to 87.9%] than standard colposcopy alone (57.91%, 95% CI 47.2% to 67.9%), but with a lower specificity (70.40%, 95% CI 59.4% to 79.5%) than colposcopy (87.41%, 95% CI 81.7% to 91.5%). (Confidential information has been removed.) The base-case cost-effectiveness results showed that adjunctive DySISmap routinely dominated standard colposcopy (it was less costly and more effective). The only exception was for high-grade referrals in a watchful-waiting clinic setting. The incremental cost-effectiveness ratio for ZedScan varied between £272 and £4922 per quality-adjusted life-year. ZedScan also dominated colposcopy alone for high-grade referrals in see-and-treat clinics. These findings appeared to be robust to a wide range of sensitivity and scenario analyses. Limitations All but one study was rated as being at a high risk of bias. There was no evidence directly comparing ZedScan with standard colposcopy. No studies directly compared DySIS and ZedScan. Conclusions The use of adjunctive DySIS increases the sensitivity for detecting CIN 2+, so it increases the number of high-grade CIN cases that are detected. However, it also reduces specificity, so that more women with no or low-grade CIN will be incorrectly judged as possibly having high-grade CIN. The evidence for ZedScan was limited, but it appears to increase sensitivity and decrease specificity compared with colposcopy alone. The cost-effectiveness of both adjunctive technologies compared with standard colposcopy, under both the HPV triage and primary screening algorithms, appears to be favourable when compared with the conventional thresholds used to determine value in the NHS. Future work More diagnostic accuracy studies of ZedScan are needed, as are studies assessing the diagnostic accuracy for women referred to colposcopy as part of the HPV primary screening programme. Study registration This study is registered as PROSPERO CRD42017054515. Funding The National Institute for Health Research Health Technology Assessment programme." @default.
- W2895069402 created "2018-10-12" @default.
- W2895069402 creator A5002769657 @default.
- W2895069402 creator A5008351749 @default.
- W2895069402 creator A5010053250 @default.
- W2895069402 creator A5030740182 @default.
- W2895069402 creator A5049679176 @default.
- W2895069402 creator A5051891843 @default.
- W2895069402 creator A5057333295 @default.
- W2895069402 creator A5090867877 @default.
- W2895069402 date "2018-09-01" @default.
- W2895069402 modified "2023-10-09" @default.
- W2895069402 title "Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation" @default.
- W2895069402 cites W1481936127 @default.
- W2895069402 cites W1486082332 @default.
- W2895069402 cites W1517644390 @default.
- W2895069402 cites W1562778490 @default.
- W2895069402 cites W1570562883 @default.
- W2895069402 cites W1571036433 @default.
- W2895069402 cites W1586868659 @default.
- W2895069402 cites W1593173821 @default.
- W2895069402 cites W1652496446 @default.
- W2895069402 cites W1697681421 @default.
- W2895069402 cites W1757435582 @default.
- W2895069402 cites W1940121429 @default.
- W2895069402 cites W1972496255 @default.
- W2895069402 cites W1974996317 @default.
- W2895069402 cites W1978318366 @default.
- W2895069402 cites W1980663262 @default.
- W2895069402 cites W1985231213 @default.
- W2895069402 cites W1987045012 @default.
- W2895069402 cites W1990155825 @default.
- W2895069402 cites W1991102174 @default.
- W2895069402 cites W1994567467 @default.
- W2895069402 cites W1997592201 @default.
- W2895069402 cites W2002308631 @default.
- W2895069402 cites W2004917997 @default.
- W2895069402 cites W2010084570 @default.
- W2895069402 cites W2020764941 @default.
- W2895069402 cites W2033552856 @default.
- W2895069402 cites W2038872884 @default.
- W2895069402 cites W2041694981 @default.
- W2895069402 cites W2042288760 @default.
- W2895069402 cites W2053940643 @default.
- W2895069402 cites W2055920849 @default.
- W2895069402 cites W2059883513 @default.
- W2895069402 cites W2061217282 @default.
- W2895069402 cites W2062358696 @default.
- W2895069402 cites W2067562586 @default.
- W2895069402 cites W2076928641 @default.
- W2895069402 cites W2083796093 @default.
- W2895069402 cites W2086591936 @default.
- W2895069402 cites W2098923148 @default.
- W2895069402 cites W2100722838 @default.
- W2895069402 cites W2101300044 @default.
- W2895069402 cites W2107415042 @default.
- W2895069402 cites W2113839478 @default.
- W2895069402 cites W2126727011 @default.
- W2895069402 cites W2130036154 @default.
- W2895069402 cites W2134064821 @default.
- W2895069402 cites W2134833483 @default.
- W2895069402 cites W2135125839 @default.
- W2895069402 cites W2137126670 @default.
- W2895069402 cites W2142614828 @default.
- W2895069402 cites W2149998251 @default.
- W2895069402 cites W2150799358 @default.
- W2895069402 cites W2151047141 @default.
- W2895069402 cites W2153358563 @default.
- W2895069402 cites W2161437807 @default.
- W2895069402 cites W2162638528 @default.
- W2895069402 cites W2164903605 @default.
- W2895069402 cites W2195890315 @default.
- W2895069402 cites W2313132396 @default.
- W2895069402 cites W2329180683 @default.
- W2895069402 cites W2333939702 @default.
- W2895069402 cites W2344970483 @default.
- W2895069402 cites W2363610706 @default.
- W2895069402 cites W2405312305 @default.
- W2895069402 cites W2489063059 @default.
- W2895069402 cites W2531269403 @default.
- W2895069402 cites W2591107578 @default.
- W2895069402 cites W2782341792 @default.
- W2895069402 cites W2792725997 @default.
- W2895069402 cites W3143265745 @default.
- W2895069402 cites W4237129666 @default.
- W2895069402 doi "https://doi.org/10.3310/hta22540" @default.
- W2895069402 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6204572" @default.
- W2895069402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30284968" @default.
- W2895069402 hasPublicationYear "2018" @default.
- W2895069402 type Work @default.
- W2895069402 sameAs 2895069402 @default.
- W2895069402 citedByCount "3" @default.
- W2895069402 countsByYear W28950694022021 @default.
- W2895069402 countsByYear W28950694022023 @default.
- W2895069402 crossrefType "journal-article" @default.
- W2895069402 hasAuthorship W2895069402A5002769657 @default.
- W2895069402 hasAuthorship W2895069402A5008351749 @default.
- W2895069402 hasAuthorship W2895069402A5010053250 @default.